Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs SAP SE — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while SAP SE trades at $222.91 (market cap $254.61B). The key difference: SAP SE is far larger — about 8.2× GE HealthCare Technologies Inc. Common Stock's market cap, and SAP SE pays the higher dividend (1.33%). Which is the better fit depends on your goals.
| GEHC | SAP | |
|---|---|---|
Market Cap | $30.93B | $254.61B |
Volume | 5,033,451 | 1,684,839 |
Sector | Health | Technology |
52-Week High | $88.16 | $280.46 |
52-Week Low | $59.48 | $146.38 |
Enterprise Value | $39.39B | $253.35B |
Dividend Yield | 0.23% | 1.33% |
Typical Hold Time | — | 118 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SAP trades at $219.75, up 0.87% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $36.8B in 2025 and a net income margin of 20.41%. Recent earnings show a mix of beats and one miss, while analyst consensus is a Buy with a $253.60 price target. Cloud revenue growth of 24% in Q2 2026 and AI initiatives are key drivers, though competition and margin pressures from cloud transitions pose challenges.
The outlook for SAP is positive, supported by robust cloud adoption and AI integration, offering potential upside to the consensus target. Risks include execution on AI capabilities, competitive threats from new entrants, and macroeconomic sensitivity in software spending. The stock's valuation at a P/E of 29.48 requires sustained earnings growth to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
